|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 |
| (11) | Number of the document | 2882736 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13753229.7 |
| Date of filing the European patent application | 2013-08-08 | |
| (97) | Date of publication of the European application | 2015-06-17 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/054099 |
| Date | 2013-08-08 |
| (87) | Number | WO 2014/025978 |
| Date | 2014-02-13 |
| (30) | Number | Date | Country code |
| 201261681477 P | 2012-08-09 | US |
| (72) |
TRAVERSE, John, F., US
ZHANG, Chengmin, US
FEIGELSON, Gregg, B., US
COHEN, Benjamin, M., US
LEONG, William, W., US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | PROCESSES FOR THE PREPARATION OF (S)-3-4-((4-(MORPHOLINOMETHYL) BENZYL)OXY)-1-OXOISOINDOLIN-2-YL) PIPERIDINE-2,6-DIONE AND PHARMACEUTICALLY ACCEPTABLE FORMS THEREOF |
| PROCESSES FOR THE PREPARATION OF (S)-3-4-((4-(MORPHOLINOMETHYL) BENZYL)OXY)-1-OXOISOINDOLIN-2-YL) PIPERIDINE-2,6-DIONE AND PHARMACEUTICALLY ACCEPTABLE FORMS THEREOF |